Search results
Results from the WOW.Com Content Network
Hydroxycut is a brand of dietary supplements that is marketed as a weight loss aid. Hydroxycut was originally developed and manufactured by MuscleTech Research and Development; MuscleTech was sold to Iovate Health Sciences in 2003–2004 and declared bankruptcy in 2005; Iovate continues to use MuscleTech as a brand to market Hydroxycut.
Here are additional clues for each of the words in today's Mini Crossword. NYT Mini Across Hints. 1 Across: "Vertically challenged" — HINT: It starts with the letter "S"
The abbreviation is not always a short form of the word used in the clue. For example: "Knight" for N (the symbol used in chess notation) Taking this one stage further, the clue word can hint at the word or words to be abbreviated rather than giving the word itself. For example: "About" for C or CA (for "circa"), or RE.
A clue containing a comparative or superlative always has an answer in the same degree (e.g., [Most difficult] for TOUGHEST). [6] The answer word(s) will not appear in the clue itself. The number of words in the answer is not given in the clue—so a one-word clue can have a multiple-word answer. [28]
The heavily marketed diet product line Hydroxycut has been blamed in the death of at least one person and for nearly two dozen serious ailments, prompting the U.S. Food and Drug Administration to ...
Get ready for all of the NYT 'Connections’ hints and answers for #245 on Sunday, February 11, 2024. Connections game for Sunday, February 11, 2024. The New York Times.
The term man (from Proto-Germanic *mann-"person") and words derived from it can designate any or even all of the human race regardless of their sex or age. In traditional usage, man (without an article) itself refers to the species or to humanity (mankind) as a whole. The Germanic word developed into Old English mann. In Old English, the word ...
Get ready for all of the NYT 'Connections’ hints and answers for #165 on Thursday, November 23, 2023. Connections game on Thursday, November 23, 2023. The New York Times.